Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with Cisplatin (CDDP) and Epirubicin (EPI) including Medroxyprogesterone Acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer
Titel:
Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with Cisplatin (CDDP) and Epirubicin (EPI) including Medroxyprogesterone Acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer
Auteur:
Mantovani, G. Macciò, A. Lai, P. Massa, E. Mudu, M.C. Manca, G. Mulas, C. Massa, D. Succu, G. Versace, R.